menu
    • menu

    Company profile for TuHURA Biosciences

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TuHURA Biosciences is a Phase 3 immuno-oncology company focused on overcoming resistance to cancer immunotherapy. Its lead candidate, IFx-2.0, is designed to enhance the efficacy of checkpoint inhibitors and is set for a Phase 3 trial with Keytruda® in advanced Merkel Cell Carcinoma. Additionally, TuHURA is developing first-in-class bi-specific ADCs and PDCs targeting Myeloid Derived Suppressor Cells to prevent T cell exhaust...
    TuHURA Biosciences is a Phase 3 immuno-oncology company focused on overcoming resistance to cancer immunotherapy. Its lead candidate, IFx-2.0, is designed to enhance the efficacy of checkpoint inhibitors and is set for a Phase 3 trial with Keytruda® in advanced Merkel Cell Carcinoma. Additionally, TuHURA is developing first-in-class bi-specific ADCs and PDCs targeting Myeloid Derived Suppressor Cells to prevent T cell exhaustion and acquired resistance, advancing novel therapies to improve patient outcomes in cancer treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TuHURA BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10500 University Center Drive Suite 110 Tampa FL 33612
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tuhurabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tuhurabio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TuHURA Biosciences Names Garofalo SVP of Clinical Operations
    TuHURA Biosciences Names Garofalo SVP of Clinical Operations

    07 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tuhura-biosciences-appoints-amanda-garofalo-mshs-as-senior-vice-president-of-clinical-operations-302735470.html

    PR NEWSWIRE
    07 Apr 2026
    Share Share
    Tuhura Biosciences Reveals 2025 Financials And Corporate Update
    Tuhura Biosciences Reveals 2025 Financials And Corporate Update

    01 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tuhura-biosciences-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-a-corporate-update-302730804.html

    PR NEWSWIRE
    01 Apr 2026
    Share Share
    Ex-J&J Exec Tendler to Lead TuHURA's VISTA Program in AML
    Ex-J&J Exec Tendler to Lead TuHURA's VISTA Program in AML

    23 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/craig-tendler-md-jnjs-former-global-head-of-oncology-clinical-development-to-lead-tuhura-biosciences-vista-program-in-aml-and-other-blood-related-cancers-302721426.html

    PR NEWSWIRE
    23 Mar 2026
    Share Share
    Tuhura Bio Restores Nasdaq Bid Price Compliance Requirement
    Tuhura Bio Restores Nasdaq Bid Price Compliance Requirement

    27 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tuhura-biosciences-regains-compliance-with-nasdaq-minimum-bid-price-requirement-302699243.html

    PR NEWSWIRE
    27 Feb 2026
    Share Share
    Tuhura Submits Ind For TBS-2025 In Blood Cancer Treatment
    Tuhura Submits Ind For TBS-2025 In Blood Cancer Treatment

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tuhura-files-investigational-new-drug-application-for-tbs-2025-in-the-treatment-of-blood-related-cancers-302688952.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    TuHURA Bio to Present at Oppenheimer Healthcare Conference
    TuHURA Bio to Present at Oppenheimer Healthcare Conference

    12 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tuhura-biosciences-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-302686189.html

    PR NEWSWIRE
    12 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search